On August 26, Nepal was hit by a major natural disaster after a glacier collapsed above the Trishuli River. The resulting floods destroyed homes, roads and bridges across affected areas, leaving communities
More
Aston Martin, EasyJet, and Ithaca Energy have been identified among the companies most likely to see significant FTSE index movement in the near term. Index reshuffles can have an outsized effect on
More
RayzeBio, a Bristol Myers Squibb company, plans to invest more than $173 million in central Indiana operations and build a major new manufacturing facility. The company will establish an approximately 450,000-square-foot facility
More
ExxonMobil remains one of the most closely watched names in the global energy sector, with investors tracking its performance against diversified upstream exploration and production peers. The upstream exploration and production segment
More
Heidi Overton, currently serving as deputy director of domestic policy at the White House, is reportedly in line to become the next FDA commissioner. President Trump is expected to put forward Overton’s
More
Trellis, a legal research company specialising in U.S. state trial court data, has significantly expanded its artificial intelligence capabilities across multiple platforms. The company has launched a new plugin for OpenAI’s ChatGPT
More
The growing wave of copyright litigation against artificial intelligence developers is raising serious concerns about the long-term accessibility of AI tools for businesses and consumers. Lawsuits filed by authors, publishers, visual artists,
More
Snapchat has unveiled a new advertising format designed specifically for pharmaceutical marketers, making it easier to include required product disclosures within in-feed ads. The updated format allows pharma advertisers to attach product
More
Nuclear energy stocks have attracted growing investor interest as the surge in artificial intelligence infrastructure creates enormous new demand for reliable, low-carbon electricity. Data centres powering AI workloads require vast and uninterrupted
More
Alembic Pharmaceuticals has received a formal warning letter from the U.S. Food and Drug Administration targeting its bioequivalence research facility in Vadodara, India. The warning letter, dated July 10, 2026, follows an
More